Argent Biopharma Ltd (ASX: RGT) Share Price and News
Price
$0.072
Movement
0.01 (-12.2%)
as at 20 Jun - Closed (20 mins delayed)
52 Week Range
$0.081 - $0.57
1 Year Return
-76.0%
Argent Biopharma Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$5.92 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
72.18 million
Earnings per share
-0.407
Dividend per share
N/A
Year To Date Return
-52.35%
Earnings Yield
N/A
Franking
-
Share Price
$0.072
Day Change
0.01 (-12.2%)
52 Week Range
$0.081 - $0.57
Yesterday's Close
$0.082
Today's Open
$0.082
Days Range
$0.07 - $0.082
Volume
13,034
Avg. Volume (1 month)
51,393
Turnover
$1,028
as at 20 Jun - Closed
Argent Biopharma Ltd (ASX: RGT)
Latest News
Share Gainers
Why cannabis company MGC Pharmaceuticals surged 13% higher today
Share Gainers
Why these ASX cannabis shares surged higher today
Share Gainers
Why these ASX cannabis shares are rocketing higher today
Share Gainers
Why cannabis company MGC Pharmaceuticals rocketed 38% higher today
Share Gainers
MGC Pharma share price lifts on botanical update
Share Gainers
The AusCann share price is flying high and up 36% in a month
Share Gainers
ASX cannabis shares have started the year on a high
Share Gainers
These small cap ASX shares are ending the week on a high
Share Gainers
Why these cannabis shares smoked the market on Tuesday
Share Market News
These 3 ASX small cap shares have stormed higher on Thursday
Share Gainers
Why MGC Pharmaceuticals Ltd (ASX:MXC) shares have rocketed 27% higher today
Share Market News
Why these 3 ASX shares are in trading halts today
RGT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About Argent Biopharma Ltd
MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. Its Endocannabinoid system covers all cells and nerves; it is the messenger of information flowing between immune system and the central nervous system. The company was founded by Nativ Segev on October 21, 2005 and is headquartered in Perth, Australia.
RGT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 19 Jun 2025 | $0.08 | $0.00 | 0.00% | 21,107 | $0.08 | $0.08 | $0.08 |
| 18 Jun 2025 | $0.08 | $0.00 | 0.00% | 47,445 | $0.09 | $0.09 | $0.08 |
| 17 Jun 2025 | $0.09 | $0.00 | 0.00% | 15,997 | $0.09 | $0.09 | $0.09 |
| 16 Jun 2025 | $0.09 | $0.00 | 0.00% | 13,873 | $0.09 | $0.09 | $0.09 |
| 13 Jun 2025 | $0.09 | $0.00 | 0.00% | 25,218 | $0.09 | $0.09 | $0.09 |
| 12 Jun 2025 | $0.09 | $0.00 | 0.00% | 28,050 | $0.09 | $0.09 | $0.09 |
| 11 Jun 2025 | $0.09 | $0.00 | 0.00% | 16,545 | $0.09 | $0.09 | $0.09 |
| 10 Jun 2025 | $0.09 | $0.00 | 0.00% | 11,624 | $0.09 | $0.09 | $0.09 |
| 06 Jun 2025 | $0.09 | $0.00 | 0.00% | 36,097 | $0.09 | $0.10 | $0.09 |
| 05 Jun 2025 | $0.09 | $-0.01 | -10.20% | 9,156 | $0.09 | $0.10 | $0.09 |
| 04 Jun 2025 | $0.10 | $0.01 | 11.11% | 41,000 | $0.09 | $0.10 | $0.09 |
| 03 Jun 2025 | $0.09 | $-0.01 | -10.53% | 23,644 | $0.10 | $0.10 | $0.09 |
| 02 Jun 2025 | $0.10 | $0.00 | 0.00% | 27,134 | $0.10 | $0.10 | $0.09 |
| 30 May 2025 | $0.10 | $0.00 | 0.00% | 27,769 | $0.09 | $0.10 | $0.09 |
| 29 May 2025 | $0.10 | $0.00 | 0.00% | 144,824 | $0.10 | $0.10 | $0.09 |
| 28 May 2025 | $0.10 | $0.00 | 0.00% | 32,046 | $0.10 | $0.10 | $0.10 |
| 27 May 2025 | $0.09 | $-0.01 | -10.10% | 237,812 | $0.10 | $0.10 | $0.09 |
| 26 May 2025 | $0.10 | $-0.02 | -17.39% | 81,352 | $0.10 | $0.10 | $0.09 |
| 23 May 2025 | $0.12 | $0.01 | 9.09% | 7,579 | $0.12 | $0.12 | $0.11 |
| 22 May 2025 | $0.11 | $0.00 | 0.00% | 26,940 | $0.11 | $0.11 | $0.11 |
| 21 May 2025 | $0.11 | $-0.01 | -8.70% | 218,154 | $0.11 | $0.12 | $0.11 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 15 Oct 2024 | Roby Zomer | Buy | 4,000,000 | $1,640,000 |
As advised by the company.
|
| 10 Sep 2024 | Roby Zomer | Buy | 1,258,500 | $503,400 |
Off-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Daniel Robinson | Non-Executive Director | Dec 2023 |
Mr Robinson has been appointed as a Non-Executive Director of the Company effective immediately. Mr Robinson has over 20 years of experience in a broad range of corporate roles across stockbroking, corporate advisory, investor relations and governance. He is an experienced Company Secretary and Director of both private and listed companies. Additionally, Mr Robinson is a Member of the Australian Institute of Company Directors.
|
| Mr Roby Reuven Zomer | Chief Executive OfficerManaging Director | Feb 2016 |
Mr Zomer is an executive with experience in the biopharmaceutical and biotech industries. As the CEO of the company, Roby has demonstrated has driven strategic growth, managed financial operations, and ensured compliance with industry-specific standards. He also served as the Chairman of the Board for Graft Polymer, overseeing the implementation of advanced polymer solutions in the Biotech, Automotive and Recycling sectors. Roby's entrepreneurial background includes founding and leading Green City Urban Recycling, a pioneering Israeli company focused on biofuel production. His innovative work in this field contributed to national energy independence initiatives and led to the company's acquisition by Rafael Advanced Defense Systems. With an industrial engineering and management foundation, Roby Zomer brings a blend of technical and strategic skills to his professional endeavors.
|
| Mr Gary Hermon | Non-Executive Director | Mar 2025 |
Mr Hermon is a Company Director with over 30 years of experience in telecommunications, electrical systems, and infrastructure rollout. Throughout his career, he has managed projects for clients, including Hewlett-Packard, the Victorian Government, BP, and ExxonMobil. Previously, Mr Hermon founded Hercomm Cables & Security, where he managed nationwide rollouts for Hewlett-Packard and the Victorian Government. He also has experience overseeing electrical systems and communications for BP and ExxonMobil in Indonesia, India, and Papua New Guinea.
|
| Mr Rowan Harland | Company Secretary | Mar 2023 |
-
|
| Rowan Harland | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Oak Capital Partners Llc | 8,370,718 | 17.29% |
| Group Capital Llc | 3,913,812 | 8.09% |
| David Safren | 3,405,016 | 7.03% |
| Citicorp Nominees Pty Limited | 2,301,084 | 4.75% |
| Shlomie Bierman | 2,230,874 | 4.61% |
| Computershare Clearing Pty Ltd <Ccnl Di A/C> | 2,099,936 | 4.34% |
| Isamar Margareten | 1,956,906 | 4.04% |
| Mr Shachar Shimony | 1,933,000 | 3.99% |
| Yaakov Safren | 1,643,802 | 3.40% |
| Jacob Goldstein | 1,623,072 | 3.35% |
| Yoram Drucker | 1,604,664 | 3.32% |
| Yosef Safren | 1,565,526 | 3.23% |
| Shalom Safren | 1,448,112 | 2.99% |
| Bioheka Limited | 1,258,500 | 2.60% |
| Mrs Yifat Steuer | 1,117,194 | 2.31% |
| Eliron Yaron | 750,000 | 1.55% |
| A1 Invest Llc | 625,000 | 1.29% |
| Mr Itay David Nissim | 600,000 | 1.24% |
| Mr Amir Polak | 592,626 | 1.22% |
| Joseph Schwartz | 547,934 | 1.14% |